EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Mycophenolate mofetil for the treatment of chronic graft versus host disease of the liver



Mycophenolate mofetil for the treatment of chronic graft versus host disease of the liver



Blood 94(10 SUPPL 1 PART 1): 159a, Nov 15




(PDF emailed within 1 workday: $29.90)

Accession: 035360144

Download citation: RISBibTeXText



Related references

The use mycophenolate mofetil in the treatment of refractory chronic graft versus host disease. Blood 92(10 SUPPL 1 PART 1-2): 346B, Nov 15, 1998

Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 11(4): 307-313, 2005

Treatment of acute and chronic graft versus host disease with mycophenolate mofetil. Blood 94(10 SUPPL 1 PART 2): 368b, Nov 15, 1999

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease. Blood 113(21): 5074-5082, 2009

Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease. Annals of Hematology 84(10): 681-685, 2005

Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease. International Journal of Hematology 83(1): 80-85, 2006

Mycophenolate mofetil as salvage treatment for steroid-refractory chronic graft versus-host disease in children. Blood 98(11 Part 1): 398a, November 16, 2001

A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease. International Journal of Hematology 91(3): 464-470, 2010

Mycophenolate mofetil (MMF) for refractory chronic graft versus host disease (cGvHD). Haematologica 88(8): Elt28; Author Reply Elt29-Elt28; Author Reply Elt29, 2003

Response to mycophenolate mofetil therapy for refractory chronic graft-versus-host disease. Haematologica 88(7): 837-839, July, 2003

Salvage therapy with mycophenolate mofetil and FK-506 for refractory chronic graft-versus-host disease. Blood 92(10 SUPPL 1 PART 1-2): 457A, Nov 15, 1998

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. Bone Marrow Transplantation 24(5): 517-520, Sept 1, 1999

Mycophenolate mofetil-induced colitis with graft versus host disease-like features in a liver transplant recipient. Indian Journal of Pathology & Microbiology 55(4): 506-508, 2013

Treatment of severe bone marrow graft versus host disease with mycophenolate mofetil. Journal of Allergy & Clinical Immunology 107(2): S297, February, 2001

Mycophenolate mofetil as rescue therapy for high-risk steroid-refractory chronic graft versus-host-disease. Pediatric Research 53(4 Part 2): 275A, April, 2003